Test Code WGSDX Whole Genome Sequencing for Hereditary Disorders, Varies
Ordering Guidance
The American College of Medical Genetics and Genomics recommends that whole genome sequencing be considered as a first-tier or second-tier test for patients with one or more congenital anomalies, or developmental delay or intellectual disability with age of onset prior to 18 years.(1)
If a specific diagnosis is suspected, single gene or panel testing may be a more appropriate first-tier testing option.
This test is for affected patients (probands) only. For family member specimens being sent as comparators, order CMPRG / Family Member Comparator Specimen for Genome Sequencing, Varies. If this test is ordered on a family member comparator, this test will be canceled and CMPRG performed as the appropriate test.
This test is not appropriate for identification of somatic variants in solid tumors, other malignancies, or other abnormal tissues. Multiple oncology (cancer) gene panels are available. For more information see Hematology, Oncology, and Hereditary Test Selection Guide. If testing for other malignancies is needed, contact the laboratory for test selection guidance.
This testing does not provide genotyping of patients for pharmacogenomic purposes. For an assessment of genes with strong drug-gene associations, order PGXQP / Focused Pharmacogenomics Panel, Varies.
Targeted testing for familial variants (also called site-specific or known variant testing) is available for variants identified by this test. See FMTT / Familial Variant, Targeted Testing, Varies. To obtain more information about this testing option, call 800-533-1710.
Prenatal specimens (amniocentesis or chorionic villi) are not currently accepted for this test.
Additional Testing Requirements
To order whole genome sequencing for the patient and the family member comparator specimens, see the following steps:
1. Order this test (WGSDX) on the patient (proband).
2. Order CMPRG / Family Member Comparator Specimen for Genome Sequencing, Varies on all family members' specimens being submitted as comparators.
 a. When available, the patient's biological mother and biological father are the preferred family member comparators.
 b. If one or both of the patient's biological parents are not available for testing, specimens from other first-degree relatives (siblings or children) can be used as comparators. Testing typically includes up to two family member comparators. Contact the laboratory at 800-533-1710 for approval to send specimens from other relatives or to send the patient and three first-degree relatives (quad).
 c. The cost of analysis for family member comparator specimens is applied to the patient's (proband's) test. Family members will not be charged separately.
3. Collect patient (proband) and family member specimens. Label specimens with full name and birthdate. Do not label family members' specimens with the proband's name.
4. For each family, complete the following portions of the Whole Genome Sequencing: Ordering Checklist. A separate form is not needed for each family member.
 a. Patient Information is required for all clients.
 b. Informed Consent is required for New York State clients.
 c. If the patient wishes to opt-out of receiving secondary findings or change the DNA storage selection, select the appropriate boxes in the Informed Consent section.
5. Attach clinic notes from specialists relevant to patient's clinical features, if available.
6. Attach pedigree, if available.
7. Send paperwork to the laboratory along with the specimens. If not sent with the specimens, fax a copy of the paperwork to 507-284-1759, Attn: WGS Genetic Counselors.
For more information see Whole Exome and Genome Sequencing Information and Test Ordering Guide.
Shipping Instructions
Specimen preferred to arrive within 96 hours of collection.
Necessary Information
Whole Genome Sequencing: Ordering Checklist is required for all patients, and Informed Consent is required for New York clients. Fill out one form for the family and send with the specimens.
Specimen Required
Patient Preparation: A previous bone marrow transplant from an allogenic donor will interfere with testing. For instructions for testing patients who have received a bone marrow transplant, call 800-533-1710.
Submit only 1 of the following specimens for each family member.
Specimen Type: Whole blood
Container/Tube:
Preferred: Lavender top (EDTA) or yellow top (ACD)
Acceptable: Any anticoagulant
Specimen Volume: 3 mL
Collection Instructions:
1. Invert several times to mix blood.
2. Send whole blood specimen in original tube. Do not aliquot.
Specimen Stability Information: Ambient (preferred)/Refrigerated
Additional Information:
1. If a cord blood specimen is received, MATCC / Maternal Cell Contamination, Molecular Analysis, Varies will be performed at an additional charge; maternal blood sample is required.
2. To ensure minimum volume and concentration of DNA is met, the preferred volume of blood must be submitted. Testing may be canceled if DNA requirements are inadequate.
Specimen Type: Skin biopsy
Supplies: Fibroblast Biopsy Transport Media (T115)
Container/Tube: Sterile container with any standard cell culture media (eg, minimal essential media, RPMI 1640). The solution should be supplemented with 1% penicillin and streptomycin.
Specimen Volume: 4-mm punch
Specimen Stability Information: Refrigerated (preferred)/Ambient
Additional Information: A separate culture charge will be assessed under CULFB / Fibroblast Culture for Biochemical or Molecular Testing. An additional 3 to 4 weeks is required to culture fibroblasts before genetic testing can occur.
Specimen Type: Cultured fibroblast
Container/Tube: T-25 flask
Specimen Volume: 2 Flasks
Collection Instructions: Submit confluent cultured fibroblast cells from a skin biopsy from another laboratory. Cultured cells from a prenatal specimen will not be accepted.
Specimen Stability Information: Ambient (preferred)/Refrigerated (<24 hours)
Additional Information: A separate culture charge will be assessed under CULFB / Fibroblast Culture for Biochemical or Molecular Testing. An additional 3 to 4 weeks is required to culture fibroblasts before genetic testing can occur.
Specimen Type: Saliva
Patient Preparation: Patient should not eat, drink, smoke, or chew gum 30 minutes prior to collection.
Supplies: Saliva Swab Collection Kit (T786)
Specimen Volume: 1 Swab
Collection Instructions: Collect and send specimen per kit instructions.
Specimen Stability Information: Ambient 30 days
Additional Information: Due to lower quantity/quality of DNA yielded from saliva, some aspects of the test may not perform as well as DNA extracted from a whole blood sample. When applicable, specific gene regions that were unable to be interrogated will be noted in the report. Alternatively, additional specimen may be required to complete testing.
Specimen Type: Muscle tissue biopsy
Supplies: Muscle Biopsy Kit (T541)
Collection Instructions: Prepare and transport specimen per instructions in Muscle Biopsy Specimen Preparation Instructions.
Specimen Volume: 10 to 80 mg
Specimen Stability Information: Frozen (preferred)/Ambient/Refrigerated
Forms
1. Whole Genome Sequencing: Ordering Checklist is required
2. New York Clients-Informed consent is required and is included in the above form. Document on the request form or electronic order that a copy is on file.
3. If not ordering electronically, complete, print, and send 1 of the following forms with the specimen:
Useful For
Serving as a first-tier test to identify a molecular diagnosis in patients with suspected genetic disorders, which can allow for:
-Better understanding of the natural history/prognosis
-Targeted management (anticipatory guidance, management changes, specific therapies)
-Predictive testing of at-risk family members
-Testing and exclusion of disease in siblings or other relatives
-Recurrence risk assessment
Serving as a second-tier test for patients in whom previous genetic testing was negative
Providing a potentially cost-effective alternative to establishing a molecular diagnosis compared to performing multiple independent molecular assays(1)
Reflex Tests
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
G227 | Number of Comparators for WGSDX | No, (Bill Only) | No |
MATCC | Maternal Cell Contamination, B | Yes | No |
CULFB | Fibroblast Culture for Genetic Test | Yes | No |
Testing Algorithm
If a cord blood specimen is received, maternal cell contamination testing will be added and performed at an additional charge.
Skin biopsy or cultured fibroblast specimens:
If a skin biopsy is received, fibroblast culture testing will be performed at an additional charge. If viable cells are not obtained, the client will be notified.
Special Instructions
Method Name
Next-Generation Sequencing (NGS) followed by Sanger Sequencing, Quantitative Polymerase Chain Reaction (qPCR), or other methods, as needed.
Reporting Name
Whole Genome SequencingSpecimen Type
VariesSpecimen Minimum Volume
Whole blood: 1 mL; Other specimen types: See Specimen Required
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Varies | Ambient (preferred) | ||
Frozen | |||
Refrigerated |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Reference Values
An interpretive report will be provided.
Day(s) Performed
Varies
Report Available
84 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
81425-Patient only
81425, 81426-Patient and one family member comparator sample (duo) (as appropriate)
81425, 81426 x 2-Patient and two family member comparator samples (trio or non-traditional trio) (as appropriate)
81425, 81426 x 3-Patient and three family member comparator samples (quad) (as appropriate)
88233-Tissue culture, skin, solid tissue biopsy (if appropriate)
88240-Cryopreservation (if appropriate)
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
WGSDX | Whole Genome Sequencing | 86206-0 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
614364 | Interpretation | 69047-9 |
614464 | Specimen | 31208-2 |
614317 | Source | 31208-2 |
614473 | Released By | 18771-6 |